Martin Lange
Corporate Officer/Principal at NOVO NORDISK A/S
Network origin in Martin Lange first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
100
| Public Company | Pharmaceuticals: Major | 100 |
University of Copenhagen
90
| College/University | Other Consumer Services | 90 |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.
6
| Subsidiary | Biotechnology | 6 |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA.
5
| Holding Company | Medical Specialties | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Lange via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | President Chairman Chief Executive Officer Public Communications Contact Chief Executive Officer Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Chairman Chief Executive Officer Director/Board Member | |
| University of Aarhus | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Human Resources Officer Director/Board Member | |
Antoax A/S
 Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Financial Conglomerates | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| NNIT A/S | Information Technology Services | Chairman Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Chairman Director/Board Member Director/Board Member Chairman | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Chairman Director/Board Member Chief Executive Officer | |
Copenhagen Infrastructure Partners P/S
 Copenhagen Infrastructure Partners P/S Investment ManagersFinance Copenhagen Infrastructure Partners P/S (CIP) is a private equity firm founded- in 2012 by Jakob Baruël Poulsen, Christian Skakkebæk, Torsten Lodberg Smed, and Rune Bro Róin. The firm is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor Founder Private Equity Investor Private Equity Investor | |
Pharmacosmos Holding A/S
 Pharmacosmos Holding A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos Holding A/S conducts business with the development of pharmaceutical, chemical, and technical products and processes. It also acquires, owns, and administers rights in connection therewith; and to own shares in companies engage in the development, production, and trade of pharmaceutical, chemical, and technical products. The company was founded on October 12, 1965 and is headquartered in Holbaek, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chairman | |
| ORSTED A/S | Electric Utilities | Director/Board Member Chief Executive Officer President | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Danish Academy of Technical Sciences | College/University | Director/Board Member President Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Falck A/S
 Falck A/S Services to the Health IndustryHealth Services Falck A/S offers emergency assistance, rescue, healthcare, and training services. It provides emergency medical services to people through their ambulances, fire-fighting, fire training, and consultancy services to industrial customers; assistance in airports within the areas of fire services and personal assistance to travelers; and fire services and emergency services in airports. The firm also facilitates roadside assistance in case of an accident or breakdown of cars, trucks, busses, caravans, trailers, bicycles, motorcycles, and boats; travel assistance services to leisure travelers, business travelers, and expatriates; and fleet management services, as well as installs and services alarms in private homes and places of businesses. It also owns shares or other securities of domestic and foreign companies. The company was founded on August 23, 2004 and is headquartered in Copenhagen, Denmark. | Services to the Health Industry | Director/Board Member Chief Executive Officer Chairman | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Falck Danmark A/S
 Falck Danmark A/S Other TransportationTransportation Falck Danmark A/S offers ambulance service, fire fighting, roadside assistance, and non-emergency patient transport. The company was founded on October 3, 1906 and is headquartered in Copenhagen, Denmark. | Other Transportation | Director/Board Member Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Novo Nordisk Region Aameo & Latam A/S
 Novo Nordisk Region Aameo & Latam A/S Financial ConglomeratesFinance Novo Nordisk Region International Operations A/S holds ownership interests in companies that operates within investment and financing activities. The firm also invests capital in companies and real estate. The company was founded in January 1, 2002 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Steno Diabetes Center A/S | Chairman Chairman | ||
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Sales & Marketing Chairman | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Novo Nordisk Health Care AG
 Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| University of Uppsala | College/University | Undergraduate Degree Doctorate Degree | |
Novo Nordisk Region Europe A/S
 Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman | |
| Novo Nordisk Haemophilia Foundation | Corporate Officer/Principal Corporate Officer/Principal | ||
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member Chief Operating Officer | |
| Danmark-Amerika Fondet | Chairman Director/Board Member | ||
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
| ROYAL UNIBREW A/S | Beverages: Alcoholic | Chairman Chairman | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The private company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CONVATEC GROUP PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Director/Board Member Chief Executive Officer | |
| COLOPLAST A/S | Medical Specialties | Chief Executive Officer Corporate Officer/Principal |
Statistics
International
| Denmark | 33 |
| United States | 8 |
| United Kingdom | 6 |
| France | 3 |
| Belgium | 2 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 9 |
| Finance | 7 |
| Consumer Non-Durables | 6 |
| Health Services | 3 |
Operational
| Director/Board Member | 480 |
| Corporate Officer/Principal | 159 |
| Chairman | 155 |
| Independent Dir/Board Member | 106 |
| Chief Executive Officer | 89 |
Most connected contacts
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Tommy Pedersen | 43 |
| Henrik Poulsen | 37 |
| Sten Scheibye | 31 |
| Martin MacKay | 28 |
| Christian Vinding Thomsen | 27 |
| Thomas Paul Koestler | 26 |
| Kim Esben Høibye | 25 |
| Sylvie Grégoire | 25 |
| Jesper Brandgaard | 25 |
| Helge Lund | 24 |
| Per Bjørnsholm | 23 |
| Lise Kingo | 23 |
| Tim Yi He | 22 |
| Lars Rebien Sørensen | 22 |
- Stock Market
- Insiders
- Martin Lange
- Company connections